Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Lowered to $203 at Barclays

August 8, 2024 5:12 AM
Barclays analyst Gena Wang lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles